Clinical Trial Update: Comparative Study of Modified Release (MR) Tacrolimus/Mycophenolate Mofetil (MMF) in de Novo Kidney Transplant Recipients [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing modified-release tacrolimus with mycophenolate mofetil in de novo kidney transplant recipients has completed, with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)
• Prograf (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Kidney Transplantation | Phase 3 | Status: COMPLETED | Results posted: 2013-09-26